What is the long-term trend for Arbutus Biopharma Corporation's available for sale investments?

Over 3 years (2020 to 2025), Arbutus Biopharma Corporation's available for sale investments has grown at a 1.1% compound annual growth rate (CAGR), from $71M to $73.46M.

Arbutus Biopharma Corporation ABUS Available for sale investments

Available for sale investments at other companies

AbCellera Biologics Inc.ABCL

——

Ligand PharmaceuticalsLGND

——

BioCryst PharmaceuticalsBCRX

——

Other financials

Income statement

See full

Revenue$179.1M+10,055%

Operating income$168.9M+757%

Net income$169.7M+792%

EPS (diluted)$0.87+769%

Balance sheet

See full

Cash & equivalents$23.7M-36.1%

Total debt$631.0K-46.9%

Total equity$260.2M+229%

Total assets$277.2M+137%

Cash flow

See full

Operating cash flow-$8.1M+39.4%

CapEx--100%

Free cash flow-$4.7M+55.0%

Valuation

See full

Market cap$871.14M+32.6%

Enterprise value$848.07M+36.6%

P/E5.4×—

P/S4.6×-98.0×

Profitability

See full

Operating margin81.7%+42.1pp

Net margin84%+43.4pp

FCF margin-281.5%-119pp

Returns & leverage

See full

Return on equity94.7%+65.1pp

Debt / equity0×0.0×

Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arbutus Biopharma Corporation's available for sale investments?: Arbutus Biopharma Corporation (ABUS) reported available for sale investments of $71.52M in Q1 2026.
How has Arbutus Biopharma Corporation's available for sale investments changed year-over-year?: Arbutus Biopharma Corporation's available for sale investments decreased by 5.4% year-over-year, from $75.63M to $71.52M.
What is the long-term trend for Arbutus Biopharma Corporation's available for sale investments?: Over 3 years (2020 to 2025), Arbutus Biopharma Corporation's available for sale investments has grown at a 1.1% compound annual growth rate (CAGR), from $71M to $73.46M.